Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Anildeep Singh
ResearcherPublications, citations & collaboration network
Anildeep Singh is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 10 works, 20 citations, an h-index of 3 and an i10-index of 0.
10
Works
20
Citations
3
h-index
0
i10-index
IDs:OpenAlex
How has Anildeep Singh's publication output changed over time?
ScholarIQpublication output · 2023–2026
Output grew100% over the shown period — from 1 works in 2023 to 2 in 2026.
1
4
3
2
2023202420252026
What are the most-cited papers on Anildeep Singh?
ScholarIQmost cited works
Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial
Byung Ha Chung, Jian Huang, Hiroji Uemura, Young Deuk Choi, Zhangqun Ye, Hiroyoshi Suzuki, Taek Won Kang, Dalin He, Jae Young Joung, Sabine Brookman‐May, Sharon McCarthy, Amitabha Bhaumik, Anildeep Singh, Suneel Mundle, Simon Chowdhury, Neeraj Agarwal, Dingwei Ye, Kim N., Hirotsugu Uemura
S78604184. 20237 CitationsOPEN ACCESS
Prostate‐specific antigen kinetics in Asian patients with metastatic castration‐sensitive prostate cancer treated with apalutamide in the <scp>TITAN</scp> trial: A post hoc analysis
Dingwei Ye, Hirotsugu Uemura, Byung Ha Chung, Hiroyoshi Suzuki, Suneel Mundle, Amitabha Bhaumik, Anildeep Singh, Simon Chowdhury, Neeraj Agarwal, Kim N., Jian Huang
S134892809. 20247 Citations
Understanding Experiences and Needs of Patients With Prostate Cancer Across Asia-Pacific: A Cross-Sectional Mixed-Methods Study
Ben Tran, Atsushi Mizokami, Shian‐Shiang Wang, Frank Yonghong Li, Tsutomu Takeuchi, Paul Bain, Yiting Liu, Chan Young Maeng, Anildeep Singh, Naomi Kishiwada, Marie Simone Cheng, Regina Gowindah, Jennifer Si, Hyun Ho Han
JU Open Plus. 20244 CitationsOPEN ACCESS
UFO registry: final analysis of baseline data from patients with advanced prostate cancer in Asia
Dingwei Ye, Ravindran Kanesvaran, Edmund Chiong, Bannakij Lojanapiwat, Yeong‐Shiau Pu, Sudhir Kumar Rawal, Ong Teng Aik, Hao Zeng, Byung Ha Chung, Md Yusoff Noor Ashani, Chikara Οhyama, Choung‐Soo Kim, Zuquan Hu, Yuh‐Shyan Tsai, Azad Hassan Abdul Razack, Anildeep Singh, Yanfang Liu, Hirotsugu Uemura
S41085503. 20241 CitationsOPEN ACCESS
Efficacy and safety of apalutamide in metastatic castration sensitive prostate cancer patients with a prior history of cardiovascular or metabolic risk factors: A post-hoc analysis of the TITAN study.
Arun Azad, Dingwei Ye, Hiroji Uemura, Amitabha Bhaumik, Michael Eisbacher, Anildeep Singh, Sharon McCarthy, Suneel Mundle, Kim N., Neeraj Agarwal
Journal of Clinical Oncology. 20251 Citations
Related on ScholarIQ
Johnson & Johnson (Singapore)
Institution
Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial
Paper
Prostate‐specific antigen kinetics in Asian patients with metastatic castration‐sensitive prostate cancer treated with apalutamide in the <scp>TITAN</scp> trial: A post hoc analysis
Paper
Understanding Experiences and Needs of Patients With Prostate Cancer Across Asia-Pacific: A Cross-Sectional Mixed-Methods Study
Paper
UFO registry: final analysis of baseline data from patients with advanced prostate cancer in Asia
Paper
Efficacy and safety of apalutamide in metastatic castration sensitive prostate cancer patients with a prior history of cardiovascular or metabolic risk factors: A post-hoc analysis of the TITAN study.
Paper